Imaging agent developed for earlier and cheaper diagnosis of Parkinson's
This article was originally published in Clinica
Executive Summary
US scientists have developed a new imaging agent for Parkinson's disease which could allow doctors to diagnose the disease earlier and more accurately than is currently possible. Furthermore, the agent can also be used with a cheap, rapid and widely available imaging technology.
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.